Venöse Thromboembolien

Blann AD, Lip GYH (2006) Venous thromboembolism. BMJ 332: 215–219 White RH (2003) The epidemiology of venous thromboembolism. Circulation 107 [Suppl 1]: I4–I8 Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107 [Suppl 1]: I9–I16 Goldhaber SZ (2004) Pulmonary embolism. Lancet 363: 1295–1305 Garcia D, Ageno W, Libby E (2005) Update on the diagnosis and management of pulmonary embolism. Br J Haematol 131: 301–312 Ho WK, Hankey GJ, Lee CH, Eikelboom JW (2005) Venous thromboembolism: diagnosis and management of deep vein thrombosis. Med J Aust 182: 476–481 Lee CH, Hankey GJ, Ho WK, Eikelboom JW (2005) Venous thromboembolism: diagnosis and management of pulmonary embolism. Med J Aust 182: 569–574 PIOPED II Investigators (2006) Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 354: 2317–2327 Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE (2004) Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 [3 Suppl]: 401S–428S Hirsh J, Raschke R (2004) Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 [3 Suppl]: 188S–203S Eichinger S (2005) Treatment of venous thromboembolism. Wien Med Wochenschr 155 (1–2): 7–10 Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 [3 Suppl]: 204S–233S Weitz JI, Hirsh J, Samama MM (2004) New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 [3 Suppl]: 265S–286S Ost D, Tepper J, Mihara H, Lander O, Heinzer R, Fein A (2005) Duration of anticoagulation following venous thromboembolism: a meta-analysis. JAMA 294: 706–715 Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349: 1695–1702 Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140: 867–873 Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162: 1833–1840